Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.
2.

Potential Role of ADRA2A Genetic Variants in the Etiology of ADHD Comorbid With Tic Disorders.

Xu D, Liu L, Li H, Sun L, Yang L, Qian Q, Wang Y.

J Atten Disord. 2018 Feb 1:1087054718757646. doi: 10.1177/1087054718757646. [Epub ahead of print]

PMID:
29482474
3.

Systemic administration of guanfacine improves food-motivated impulsive choice behavior primarily via direct stimulation of postsynaptic α2A-adrenergic receptors in rats.

Nishitomi K, Yano K, Kobayashi M, Jino K, Kano T, Horiguchi N, Shinohara S, Hasegawa M.

Behav Brain Res. 2018 Jun 1;345:21-29. doi: 10.1016/j.bbr.2018.02.022. Epub 2018 Feb 21.

PMID:
29476896
4.

Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.

Myer NM, Boland JR, Faraone SV.

Mol Psychiatry. 2018 Sep;23(9):1-8. doi: 10.1038/mp.2017.234. Epub 2017 Dec 12.

PMID:
29230023
5.

Blockade of α2-adrenergic receptors in prelimbic cortex: impact on cocaine self-administration in adult spontaneously hypertensive rats following adolescent atomoxetine treatment.

Baskin BM, Nic Dhonnchadha BÁ, Dwoskin LP, Kantak KM.

Psychopharmacology (Berl). 2017 Oct;234(19):2897-2909. doi: 10.1007/s00213-017-4681-y. Epub 2017 Jul 20.

6.

Specific Genes Associated with Adverse Events of Methylphenidate Use in the Pediatric Population: A Systematic Literature Review.

Joensen B, Meyer M, Aagaard L.

J Res Pharm Pract. 2017 Apr-Jun;6(2):65-72. doi: 10.4103/jrpp.JRPP_16_161. Review.

7.

The safety of extended-release drug formulations for the treatment of ADHD.

Childress A.

Expert Opin Drug Saf. 2017 May;16(5):603-615. doi: 10.1080/14740338.2017.1317344. Review.

PMID:
28393639
8.

Function of brain α2B-adrenergic receptor characterized with subtype-selective α2B antagonist and KO mice.

Luhrs L, Manlapaz C, Kedzie K, Rao S, Cabrera-Ghayouri S, Donello J, Gil D.

Neuroscience. 2016 Dec 17;339:608-621. doi: 10.1016/j.neuroscience.2016.10.024. Epub 2016 Oct 14.

PMID:
27751959
9.

Genetic Variations in Attention Deficit Hyperactivity Disorder Subtypes and Treatment Resistant Cases.

Unal D, Unal MF, Alikasifoglu M, Cetinkaya A.

Psychiatry Investig. 2016 Jul;13(4):427-33. doi: 10.4306/pi.2016.13.4.427. Epub 2016 Jul 25.

10.

Cognitive Effects of Stimulant, Guanfacine, and Combined Treatment in Child and Adolescent Attention-Deficit/Hyperactivity Disorder.

Bilder RM, Loo SK, McGough JJ, Whelan F, Hellemann G, Sugar C, Del'Homme M, Sturm A, Cowen J, Hanada G, McCracken JT.

J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):667-73. doi: 10.1016/j.jaac.2016.05.016. Epub 2016 Jun 7.

11.

Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd).

Alamo C, López-Muñoz F, Sánchez-García J.

Actas Esp Psiquiatr. 2016 May;44(3):107-12. Epub 2016 May 1. Review.

12.

Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine).

Mattes JA.

J Am Acad Psychiatry Law. 2016 Jun;44(2):151-7.

PMID:
27236168
13.

A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study.

Hegvik TA, Jacobsen KK, Fredriksen M, Zayats T, Haavik J.

J Neural Transm (Vienna). 2016 Aug;123(8):859-65. doi: 10.1007/s00702-016-1540-7. Epub 2016 Apr 18.

14.

Genotyping of single nucleotide polymorphisms related to attention-deficit hyperactivity disorder.

Tortajada-Genaro LA, Mena S, Niñoles R, Puigmule M, Viladevall L, Maquieira Á.

Anal Bioanal Chem. 2016 Mar;408(9):2339-45. doi: 10.1007/s00216-016-9332-3. Epub 2016 Feb 1.

PMID:
26832728
15.

Perception of emotion in facial stimuli: The interaction of ADRA2A and COMT genotypes, and sex.

Tamm G, Kreegipuu K, Harro J.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:87-95. doi: 10.1016/j.pnpbp.2015.07.012. Epub 2015 Jul 30.

PMID:
26234518
16.

Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder.

Sánchez-Mora C, Richarte V, Garcia-Martínez I, Pagerols M, Corrales M, Bosch R, Vidal R, Viladevall L, Casas M, Cormand B, Ramos-Quiroga JA, Ribasés M.

Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):480-491. doi: 10.1002/ajmg.b.32340. Epub 2015 Jul 14.

PMID:
26174753
17.

A Population Based Study of the Genetic Association between Catecholamine Gene Variants and Spontaneous Low-Frequency Fluctuations in Reaction Time.

Bastiaansen JA, Cummins TD, Riese H, van Roon AM, Nolte IM, Oldehinkel AJ, Bellgrove MA.

PLoS One. 2015 May 15;10(5):e0126461. doi: 10.1371/journal.pone.0126461. eCollection 2015.

18.

Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches.

Kim JW, Sharma V, Ryan ND.

Int J Neuropsychopharmacol. 2015 May 10;18(11):pyv052. doi: 10.1093/ijnp/pyv052.

19.

Prefrontal cortical α2A-adrenoceptors and a possible primate model of attention deficit and hyperactivity disorder.

Ma CL, Sun X, Luo F, Li BM.

Neurosci Bull. 2015 Apr;31(2):227-34. doi: 10.1007/s12264-014-1514-4. Epub 2015 Mar 31. Review.

20.

Deficiency of Sustained Attention in ADHD and Its Potential Genetic Contributor MAOA.

Liu L, Cheng J, Su Y, Ji N, Gao Q, Li H, Yang L, Sun L, Qian Q, Wang Y.

J Atten Disord. 2018 Jul;22(9):878-885. doi: 10.1177/1087054715574832. Epub 2015 Mar 17.

PMID:
25784069

Supplemental Content

Loading ...
Support Center